Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease

Type 3 Gaucher disease (GD3) is characterized by progressive neurological features in addition to the typical systemic manifestations. Enzyme replacement therapy (ERT), the main stay treatment for Gaucher disease (GD), is not efficacious for the neurological manifestations. Ambroxol, in combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Charkhand, Behshad, Scantlebury, Morris H., Narita, Aya, Zimran, Ari, Al-Hertani, Walla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713848/
https://www.ncbi.nlm.nih.gov/pubmed/31467847
http://dx.doi.org/10.1016/j.ymgmr.2019.100476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713848/
https://www.ncbi.nlm.nih.gov/pubmed/31467847
http://dx.doi.org/10.1016/j.ymgmr.2019.100476

Ejemplares similares